
Radiopharma Scaling Into Margin Headwinds—Execution Risk on SPECT Recovery
CDMO · radiopharma · SPECT
BSE: 530019
P/L Snapshot
Q2 FY27 · standalone
Shareholding
Pattern breakdown
P/L Trends
(in crores)

CDMO · radiopharma · SPECT

radiopharmaceuticals · capacity expansion · RUBY-FILL

pharma · cdmo · margin compression
Corporate Events
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
The Finance Committee of the Company approved the allotment …
BSE Filing ↗Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗Board Meeting
The 48th AGM will be held to receive, consider and adopt fin…
BSE Filing ↗Board Meeting
The 48th AGM will be held on August 26, 2026. The agenda in…
BSE Filing ↗Board Meeting
The meeting of the Board of Directors of the Company is sche…
BSE Filing ↗Board Meeting
The Board of Directors recommended payment of final dividend…
BSE Filing ↗Board Meeting
Inter-alia consider and approve Unaudited Standalone and Con…
BSE Filing ↗Board Meeting
Consider and approve Audited Standalone and Consolidated Fin…
BSE Filing ↗Board Meeting
Consideration and approval of Board Meeting Intimation for u…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Standalone and Consolidated F…
BSE Filing ↗